Reis-Filho and colleagues concluded that genes mutated in male breast cancer are enriched for DNA repair-related genes and hypothesised that these mutations may in part account for the lack or the lower levels of TP53 mutations. The gene discussed is TP53; the disease is breast carcinoma.